Private Equity-Gesellschaften investieren enorme Summen u.a. aus Pensionfonds von Angestellten des Public Service in den USA in Fossilenergien. Pro Jahr werden so 1,17 Gigatonnen CO2-Äquivalente an Emissionen finanziert. Private Equity-Unternehmen agieren intransparent und übernehmen oft schmutzige Assets, die von transparenteren Firmen abgestoßen werden. Eine Studie listet auf, für wieviele Emissionen die große Private Equity-Firmen verantwortlich sind. https://www.theguardian.com/business/2024/oct/01/private-equity-firms-us-pensions-fossil-fuel-projects

https://www.theguardian.com/business/2022/sep/14/private-equity-dirty-energy-carlyle-warburg-pincus-kkr-climate-risks-scorecard?sara_ref=re-nl-spiegelklimabericht-2024_08_16

• for: climate departure project - potential stakeholder

{Community}

{Stakeholder Governed}

Mazumdar, S., & Thakker, D. (2020). Citizen Science on Twitter: Using Data Analytics to Understand Conversations and Networks. Future Internet, 12(12), 210. https://doi.org/10.3390/fi12120210

https://www.mdpi.com/1999-5903/12/12/210

Robson, S. G., Baum, M. A., Beaudry, J. L., Beitner, J., Brohmer, H., Chin, J., Jasko, K., Kouros, C., Laukkonen, R., Moreau, D., Searston, R. A., Slagter, H. A., Steffens, N. K., & Tangen, J. M. (2021). Nudging Open Science. PsyArXiv. https://doi.org/10.31234/osf.io/zn7vt

Ii, Y. B., Ouattara, A., Torreele, E., & Okonta, C. (2021). How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa. BMJ Global Health, 6(2), e005306. https://doi.org/10.1136/bmjgh-2021-005306

Kekecs, Z., Szaszi, B., & Aczel, B. (2020). ECO, an expert consensus procedure for developing robust scientific outputs [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/9gqru

Schwab, K. (2020, June 03). Now is the time for a “great reset.” World Economic Forum. Retrieved June 5, 2020, from https://www.weforum.org/agenda/2020/06/now-is-the-time-for-a-great-reset/

Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014). Increasing value and reducing waste in research design, conduct, and analysis. The Lancet, 383(9912), 166–175. https://doi.org/10.1016/S0140-6736(13)62227-8

Levando em conta o contexto de pressão para garantir qualidade do atendimento, os atores são capazes de uma mudança/adaptação rápida que diminua o risco de efeitos negativos nessa mudança para a Saúde 4.0?

Os atores principais: pacientes, médicos, profissionais de saúde, planos de saúde, indústria farmacêutica e governo.

Health 4.0 é centrada no paciente e nas suas necessidades.